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| INTRODUCTION

Paroxysmal atrial fibrillation (AF) occurs frequently in patients with
Wolff-Parkinson-White (WPW) syndrome, with a reported incidence of 9% to 38%. [1] [2] [3] [4] Previous studies have reported a decreased incidence in AF after successful elimination of the accessory pathway (AP), 5, 6 indicating that the AP itself may play an important role in the initiation of AF. However, paroxysmal AF still frequently recurs in some patients with WPW syndrome despite successful AP elimination. 3, 4, [7] [8] [9] The identification of patients at high risk for recurrence of AF is of clinical importance because additional therapeutic strategies are needed for these patients.
Interatrial block (IAB) denotes a conduction delay between the right and left atria that manifests in a 12-lead electrocardiogram (ECG) as a P-wave duration of >120 ms. 10, 11 A prolonged P-wave with biphasic (±) morphology in the inferior leads represents an even higher degree of IAB and has been referred to as advanced IAB. 10 The appearance of advanced IAB is frequently associated with atrial tachyarrhythmias, and has been found to predict AF in multiple clinical scenarios. [12] [13] [14] [15] [16] [17] [18] [19] [20] However, the role of advanced IAB in predicting the recurrence of AF after AP ablation in patients with WPW syndrome is unclear. Thus, in the present study, we investigated the clinical utility of advanced IAB for predicting the risk of AF recurrence in patients with verified paroxysmal AF and WPW syndrome after successful AP ablation. 
| Electrophysiological study and catheter ablation
The patients underwent an electrophysiological study after all antiarrhythmic drugs had been discontinued for at least five half-lives and before radiofrequency catheter ablation was performed. Three 
| ECG analysis
In all patients, a resting 12-lead ECG in sinus rhythm (high-pass filter, 4-fold image amplification. P-waves were measured manually using digital calipers for all 12 ECG leads to identify the longest P-wave duration, as previously described. 13 Advanced IAB was defined as a P-wave of >120 ms accompanied by a biphasic (±) morphology in the inferior leads ( Figure 1 ). 10 The ECG analysis was performed independently by two observers who were blinded to the patient details, and any differences between the observers were resolved by consensus.
| Patient follow-up
After the ablation procedure, all patients were required to visit their physician at 3, 6, and 12 months and every year thereafter. Cox proportional hazards regression was used to examine the risk of recurrence. All probability values were two-sided, and values of P < .05 were considered statistically significant.
| RESULTS
In total, 103 patients were enrolled to the study. Advanced IAB was detected in 10 (9.7%) patients. The clinical and electrophysiological characteristics of patients with and without advanced IAB are shown in (Table 3) .
| DISCUSSION
The main findings of the present study are that advanced IAB and age > 50 years were independent predictors of AF recurrence after successful AP ablation in patients with WPW syndrome.
Previous studies have shown that patients with WPW syndrome have a high incidence of paroxysmal AF. [1] [2] [3] [4] Recent studies suggest that although AP ablation alone may prevent further AF recurrence in the majority of these patients, the incidence of paroxysmal AF remains higher than that in the general population even after successful AP ablation. 3, 4, [7] [8] [9] This is supported by our finding that 15.5% Previous studies have examined several predictors of AF recurrence in patients with WPW syndrome after AP ablation. Kawabata et al. 6 investigated the relationship between the B-type natriuretic peptide (BNP) level and AF recurrence after AP ablation in patients with WPW syndrome and found that a BNP level ≥ 40 pg/mL was an independent predictive factor for AF recurrence. However, the BNP level might fluctuate because it is affected by many factors. In a study by Hiraki et al., 25 a filtered P-wave duration of >130 ms on signalaveraged electrocardiography was an independent predictor of recurrence of AF after AP ablation. In addition, Aytemir et al. 26 evaluated the predictive value of the maximum P-wave duration and P-wave dispersion on a 12-lead surface ECG in predicting AF recurrence, and their multivariate analysis showed that only a P-wave dispersion of ≥32.5 ms was an independent predictor of AF recurrence. In the present study, we evaluated the role of advanced IAB (ie, P-wave duration of >120 ms accompanied by a biphasic (±) morphology in the inferior leads on 12-lead surface ECG) in predicting the risk of AF recurrence in patients with WPW syndrome after AP ablation. The univariate and multivariate analyses showed that advanced IAB was associated with AF recurrence. Two potential mechanisms may account for these findings. First, advanced IAB is likely a presentation of AP-independent atrial electrophysiological abnormalities that remain after successful AP ablation. In support of this, advanced IAB was previously reported to reflect the underlying atrial substrate with atrial fibrosis 27, 28 and to be associated with the development of AF. [12] [13] [14] [15] [16] [17] [18] [19] [20] Second, advanced IAB may play a role in initiating and maintaining reentry circuits by promoting the occurrence of unidirectional block, 29 an important mechanism in the development of F I G U R E 2 Kaplan-Meier curves showing recurrence of atrial fibrillation (AF) in patients with and without a IAB) after accessory pathway ablation. Patients with advanced IAB had a higher rate of recurrence of AF than those without advanced IAB (90.0% vs 7.5%, respectively; P < .01 by log-rank test). aIAB, advanced interatrial block AF. Additionally, our study showed that age > 50 years was an independent predictor of AF recurrence, which is in accordance with the findings of previous studies. 3, 4, 7 Because patients with advanced IAB have a high risk of AF recurrence after AP ablation, additional interventions are required to prevent AF recurrence in this population. Pulmonary vein isolation is an established effective treatment for paroxysmal AF. 30 However, we did not assess whether pulmonary vein isolation was effective for preventing AF recurrence in patients in the present study. Although the pulmonary vein is reportedly involved in the development of paroxysmal AF in patients with WPW syndrome, 8 atrial substrate abnormalities partially determine the likelihood of AF recurrence after AP ablation in these patients. 4 Thus, the clinical efficacy of pulmonary vein isolation for preventing AF recurrence in these patients requires further study.
| LIMITATIONS
This study has several limitations. First, it is not possible to correctly measure P-wave duration before catheter ablation in patients with WPW syndrome because the delta wave overshadows the point at which the P-wave ends; therefore, the use of P-wave duration before ablation to predict the recurrence of AF in these patients is of limited value. Second, because all patients were retrospectively enrolled and underwent radio- 
| CONCLUSION
The presence of advanced IAB may be used to predict future recurrence of AF after successful AP ablation in patients with verified paroxysmal AF and WPW syndrome. 
CONFLICT OF INTEREST
The authors declare that there is no conflict of interest. 
